Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

MEMPHIS PATHOLOGY LABORATORY

NPI: 1548370745 · MEMPHIS, TN 38134 · Clinical Medical Laboratory · NPI assigned 08/30/2006

$61.43M
Total Medicaid Paid
7,389,083
Total Claims
5,895,041
Beneficiaries
429
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialVALLADARES, DINA (SENIOR DIRECTOR)
NPI Enumeration Date08/30/2006

Related Entities

Other providers sharing the same authorized official: VALLADARES, DINA

ProviderCityStateTotal Paid
PROPATH SERVICES, LLC DALLAS TX $16.79M
SEACOAST PATHOLOGY INC EXETER NH $995K
PINKUS DERMATOPATHOLOGY LABORATORY, PC MONROE MI $816K
BERNHARDT LABORATORIES INC JACKSONVILLE FL $620K
CLEVELAND SKIN PATHOLOGY LABORATORY, INC BEACHWOOD OH $609K
CARLA B. MACLEOD M.D. & ASSOCIATES LLC GAITHERSBURG MD $292K
BIOPSY DIAGNOSTICS, LLC RIDGELAND SC $255K
PINKUS DERMATOPATHOLOGY LABORATORY, PC MONROE MI $93K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 1,224,484 $9.03M
2019 1,253,253 $8.65M
2020 991,089 $10.42M
2021 1,085,612 $10.42M
2022 1,005,756 $9.20M
2023 1,042,637 $7.95M
2024 786,252 $5.76M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 125,848 107,900 $7.87M
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 190,425 158,628 $3.77M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 191,009 159,136 $3.65M
80053 Comprehensive metabolic panel 531,474 467,525 $2.18M
80061 Lipid panel 424,276 366,101 $2.16M
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 126,086 108,193 $1.95M
84443 Thyroid stimulating hormone (TSH) 306,482 266,053 $1.86M
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 167,212 141,783 $1.84M
80050 General health panel 93,510 78,577 $1.77M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 53,181 43,168 $1.71M
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 88,203 74,706 $1.50M
80081 25,070 21,565 $1.44M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 449,260 386,778 $1.41M
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 49,906 42,598 $1.24M
83036 Hemoglobin; glycosylated (A1C) 307,954 262,960 $1.05M
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 74,699 63,581 $1.03M
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 64,599 57,187 $965K
80074 39,618 31,885 $700K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 20,438 19,155 $689K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 98,837 19,198 $667K
86003 214,914 12,063 $662K
87086 Culture, bacterial; quantitative colony count, urine 161,035 137,490 $641K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 19,710 16,056 $549K
82607 85,215 73,302 $505K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 3,065 2,831 $475K
87481 66,220 10,364 $458K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 3,125 2,312 $452K
80055 14,727 12,659 $442K
81514 4,123 3,733 $437K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 4,324 3,877 $405K
88305 Level IV - Surgical pathology, gross and microscopic examination 12,475 9,029 $374K
86803 51,730 44,256 $347K
81513 8,006 7,066 $345K
84439 91,127 77,969 $336K
87077 68,050 59,961 $316K
82728 58,436 50,088 $301K
87902 3,223 2,874 $295K
84403 24,851 21,623 $288K
88142 26,983 23,320 $283K
81511 17,593 10,515 $275K
82746 48,675 41,675 $270K
86696 23,258 20,216 $260K
84702 39,561 28,088 $257K
87081 56,225 49,217 $252K
87536 8,252 7,375 $248K
87522 Neg quan hep c or qual rna 13,060 11,489 $246K
86592 98,793 85,628 $245K
83970 22,224 19,678 $244K
83655 31,333 28,587 $221K
80048 Basic metabolic panel (calcium, ionized) 70,851 61,224 $220K
83550 62,198 53,603 $219K
83880 17,950 15,228 $218K
86038 35,782 30,822 $215K
85027 81,671 70,346 $209K
84153 29,699 25,217 $207K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 5,882 5,378 $196K
83540 74,004 63,292 $192K
87186 48,052 42,395 $189K
84481 23,901 20,882 $184K
82670 12,756 11,348 $181K
36415 Collection of venous blood by venipuncture 332,717 259,478 $179K
87340 34,678 28,722 $177K
82105 18,225 15,425 $175K
87480 20,392 16,078 $174K
88141 15,690 13,235 $166K
86695 21,863 19,088 $163K
86480 8,190 7,071 $163K
83013 5,938 5,435 $162K
86235 36,771 5,825 $158K
83001 15,040 13,324 $153K
82570 81,545 68,974 $145K
83735 57,098 48,066 $138K
87510 16,969 12,931 $134K
84146 12,619 11,003 $131K
86762 15,802 12,730 $128K
83020 17,693 14,121 $127K
84480 22,787 19,633 $125K
87660 17,410 12,554 $124K
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel 427 388 $123K
82785 13,978 8,800 $118K
84270 10,735 9,423 $118K
83002 11,348 10,015 $114K
84144 10,190 8,553 $113K
86665 8,980 4,237 $113K
83525 16,552 14,679 $110K
87070 23,688 20,116 $109K
82043 55,765 49,364 $106K
82677 6,195 5,371 $104K
86703 10,827 9,454 $101K
87799 18,574 2,222 $99K
86769 4,735 3,858 $95K
84436 36,087 30,120 $90K
87511 7,900 6,054 $88K
86376 11,767 10,334 $87K
81001 66,457 57,316 $86K
86140 38,278 32,734 $83K
80164 14,243 11,859 $81K
84550 39,426 34,323 $81K
86850 16,711 13,427 $80K
80076 24,647 20,936 $76K
83516 23,069 6,907 $71K
86431 26,248 22,826 $71K
87507 344 275 $69K
82950 22,251 19,914 $69K
82248 30,153 25,469 $69K
86336 6,211 5,373 $67K
86787 8,429 6,862 $67K
87631 799 712 $65K
86360 4,681 4,090 $64K
85652 47,900 41,618 $60K
82784 22,033 7,380 $59K
84681 7,171 6,352 $58K
83690 16,363 14,372 $56K
87653 2,607 2,221 $56K
82627 4,300 3,869 $55K
86359 4,691 4,097 $54K
87512 3,717 1,662 $53K
86800 6,876 6,025 $53K
86706 11,091 9,342 $50K
82652 3,452 2,936 $49K
85660 11,200 9,700 $48K
80177 7,632 6,613 $46K
80349 5,279 3,559 $46K
82150 13,709 11,971 $45K
86225 9,685 7,201 $45K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision 4,873 4,393 $45K
87147 12,194 10,841 $44K
86780 3,803 3,279 $43K
87209 3,683 3,251 $43K
86160 14,512 5,843 $42K
84156 28,531 24,091 $41K
80361 4,490 2,612 $41K
84479 18,797 15,938 $41K
86039 8,608 7,055 $41K
82533 5,234 4,174 $41K
82550 16,275 13,855 $41K
84238 3,570 3,299 $40K
83615 12,406 10,379 $40K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 415 387 $40K
86200 7,308 6,083 $38K
85610 26,109 19,871 $38K
82947 16,735 13,986 $38K
86664 3,286 2,894 $37K
86704 7,855 6,725 $37K
86677 4,541 3,604 $37K
86147 4,665 1,746 $36K
87205 14,717 12,850 $36K
87255 1,841 1,597 $35K
88342 1,417 930 $34K
88112 1,964 1,762 $34K
87451 15,815 4,591 $34K
83021 3,450 3,134 $33K
86901 15,241 12,124 $33K
82951 4,836 4,369 $32K
84165 11,294 9,280 $31K
80069 13,651 11,820 $31K
88307 610 441 $31K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 2,766 2,373 $31K
86663 3,089 2,721 $31K
87427 4,506 4,016 $31K
82378 4,195 3,445 $29K
87045 4,560 4,076 $29K
86334 5,797 4,613 $29K
82024 1,584 1,361 $27K
80185 5,255 4,397 $27K
86694 3,123 2,854 $26K
83521 2,816 1,350 $26K
86900 15,258 12,127 $24K
84100 15,349 12,511 $23K
86146 2,301 993 $23K
85018 14,887 13,642 $23K
87529 1,289 825 $23K
82565 11,176 8,693 $22K
81596 884 789 $21K
87177 3,707 3,275 $21K
86361 2,911 2,547 $21K
83520 4,773 3,013 $20K
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision 2,540 2,335 $20K
85014 12,898 12,017 $20K
85045 10,709 9,438 $20K
84703 4,786 4,352 $20K
G0103 Prostate cancer screening; prostate specific antigen test (psa) 11,264 9,463 $20K
80178 7,471 6,030 $20K
84445 915 840 $20K
87632 219 209 $20K
86618 2,378 1,986 $19K
80197 3,510 2,700 $19K
85730 9,412 7,321 $19K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 318 269 $19K
87276 2,036 1,783 $18K
87046 4,573 4,084 $18K
86757 2,152 1,057 $18K
86258 1,848 1,091 $17K
86705 2,772 2,467 $17K
87493 548 505 $17K
87275 2,037 1,784 $16K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 563 508 $16K
83090 2,048 1,758 $16K
82977 5,654 4,722 $16K
86708 2,857 2,465 $16K
86304 2,267 1,695 $16K
86255 2,279 1,398 $16K
84207 1,892 1,611 $15K
84425 1,876 1,665 $15K
84460 6,793 5,771 $15K
85379 3,795 3,427 $15K
82140 2,969 2,499 $14K
84520 7,058 5,437 $14K
86364 1,749 1,580 $14K
84450 6,568 5,537 $13K
83883 4,306 1,507 $13K
86709 1,807 1,639 $13K
82465 6,353 5,455 $13K
80156 2,284 1,994 $12K
87563 674 652 $12K
82330 3,047 2,695 $12K
81329 207 198 $12K
87075 3,640 2,998 $11K
87449 2,077 1,827 $11K
86141 1,817 1,561 $11K
80346 3,172 1,523 $11K
88164 2,051 1,862 $11K
80175 1,555 1,347 $10K
82088 613 546 $10K
87517 683 592 $10K
88304 877 730 $10K
87015 2,680 2,261 $10K
84466 2,347 1,968 $10K
85060 2,436 1,920 $10K
87324 1,777 1,571 $10K
82247 3,927 2,856 $9K
86300 2,147 1,170 $9K
83721 2,558 2,125 $9K
87901 118 107 $9K
81025 1,956 1,622 $9K
84134 1,987 1,502 $8K
86008 3,597 1,194 $8K
86308 1,921 1,733 $8K
80183 717 623 $8K
84132 3,838 3,267 $8K
83921 1,103 1,016 $8K
82952 3,212 2,903 $8K
80365 2,217 964 $8K
83498 632 590 $7K
82671 553 495 $7K
86593 2,680 2,333 $7K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 131 92 $7K
86231 844 766 $7K
84155 7,927 6,251 $7K
86812 656 599 $7K
80324 1,333 638 $7K
86036 896 499 $6K
84484 1,482 1,283 $6K
83010 1,578 1,316 $6K
81003 7,919 6,392 $6K
87102 1,541 1,326 $6K
85007 4,146 3,396 $6K
83695 1,072 901 $6K
86015 575 502 $6K
84432 838 775 $5K
82668 1,037 962 $5K
80364 872 453 $5K
87206 2,441 1,822 $5K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 107 102 $5K
82626 428 386 $5K
82542 437 409 $5K
83698 305 277 $5K
83704 282 275 $5K
80326 863 555 $5K
86886 1,774 1,542 $5K
80159 945 710 $5K
80184 1,298 1,072 $5K
87280 489 453 $5K
80353 1,384 605 $4K
80202 981 439 $4K
82274 694 550 $4K
87338 730 670 $4K
84630 1,046 950 $4K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 464 382 $4K
82397 753 658 $4K
85240 490 416 $4K
G0432 Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening 604 229 $4K
86381 439 381 $4K
P3001 Screening papanicolaou smear, cervical or vaginal, up to three smears, requiring interpretation by physician 750 672 $4K
87273 845 440 $4K
81015 4,117 3,247 $4K
87088 781 666 $3K
82040 1,749 1,502 $3K
85613 1,162 865 $3K
86341 402 296 $3K
82232 1,039 818 $3K
84075 1,813 1,515 $3K
P3000 Screening papanicolaou smear, cervical or vaginal, up to three smears, by technician under physician supervision 471 457 $3K
84080 713 630 $3K
80162 1,021 840 $3K
82172 312 267 $3K
84295 1,577 1,267 $3K
80348 3,094 1,062 $3K
86301 450 330 $3K
86666 629 289 $3K
84244 290 273 $3K
80362 500 459 $3K
86335 301 266 $3K
80356 656 555 $3K
84305 211 195 $2K
82310 1,581 1,326 $2K
80354 1,159 550 $2K
82610 165 143 $2K
87040 747 392 $2K
87350 314 281 $2K
82525 464 414 $2K
84154 542 454 $2K
87906 27 25 $2K
87210 717 571 $2K
86645 176 150 $2K
82575 416 336 $2K
87076 555 431 $2K
85246 182 168 $2K
84160 1,689 1,443 $2K
80358 1,149 466 $2K
85384 507 419 $2K
84478 1,335 705 $2K
86644 181 152 $2K
82085 889 693 $2K
86060 344 292 $2K
89055 791 712 $2K
83993 110 104 $2K
87185 723 572 $2K
82164 300 260 $2K
85306 275 215 $1K
86668 74 68 $1K
84166 186 152 $1K
87140 342 279 $1K
82679 115 105 $1K
80355 2,357 756 $1K
80321 1,180 1,007 $1K
85245 116 104 $1K
84590 286 255 $1K
85303 251 209 $1K
85390 238 214 $1K
86765 208 184 $1K
86256 246 118 $1K
82553 231 207 $1K
85049 740 592 $966.79
86735 166 140 $924.64
82239 101 72 $894.45
86692 57 46 $885.08
81050 472 393 $845.08
80373 1,156 378 $837.09
82747 169 141 $837.01
80345 331 202 $835.34
83835 136 121 $825.23
86790 55 46 $765.99
86880 337 299 $745.32
82157 55 52 $740.62
88173 20 14 $736.02
85300 153 134 $658.54
81374 28 24 $655.83
82103 125 106 $574.33
86317 158 28 $571.11
80347 32 24 $549.61
84300 481 441 $547.82
83519 108 84 $519.41
84482 84 79 $510.80
86337 32 32 $499.82
86617 104 59 $497.68
80323 265 158 $463.90
80337 39 25 $462.71
86777 87 76 $394.51
87290 58 42 $393.24
80366 989 326 $390.28
82270 247 207 $379.04
83789 65 46 $369.04
80299 13 13 $343.59
82390 80 65 $318.37
88302 14 12 $314.64
86702 145 94 $310.82
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous 158 117 $241.50
80360 253 183 $232.56
80051 61 54 $232.50
85307 67 53 $231.48
88155 65 46 $229.71
84255 15 14 $228.44
86162 31 30 $226.65
80235 12 12 $222.99
86870 37 29 $218.88
86316 27 24 $211.51
87252 22 12 $209.70
86701 145 94 $204.04
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) 323 281 $203.59
87116 70 57 $202.32
86753 30 25 $197.96
82166 14 12 $193.50
80201 66 58 $184.48
89060 29 29 $178.61
83935 77 65 $171.90
84260 15 12 $169.42
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 21 20 $150.00
85576 17 14 $147.18
82435 101 99 $143.07
83992 233 156 $139.69
88313 30 29 $139.57
82180 44 40 $138.53
87269 12 12 $131.57
82787 156 39 $126.38
87425 16 14 $115.44
83930 53 49 $108.34
84446 13 13 $107.50
85048 56 37 $104.00
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 20 19 $103.56
86707 27 24 $102.86
80371 211 146 $91.84
85230 16 12 $77.25
82374 55 52 $64.13
80173 20 15 $62.37
83014 16 13 $51.01
82540 36 30 $49.45
87497 13 12 $42.25
87385 15 12 $26.54
82340 12 12 $26.47
82955 12 12 $19.37
84145 18 17 $13.61
36416 119 81 $0.09
80369 200 139 $0.00
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge 26 12 $0.00
99000 3,513 2,720 $0.00
80368 205 141 $0.00
87483 48 19 $0.00
80188 32 26 $0.00